Skip to main content
. 2017 Dec 20;15(3):3155–3160. doi: 10.3892/ol.2017.7668

Figure 1.

Figure 1.

Actein inhibits cell viability in a dose- and time-dependent manner. (A) Cell viability of 5 different lung cancer cell lines was assessed following treatment with 30 µM actein for 24 h. (B) cell viability of A549 and 95D was examined following treatment with different doses of actein (0, 5, 10, 20, 40 and 80 µM) for 24 h. (C) cell viability of A549 and 95D was examined following treatment with 30 µM actein for different time periods (0, 12, 24, 36 and 48 h). *P<0.05, compared with untreated A549 cells; #P<0.05, compared with untreated 95D cells.